MyFinsight

HomeBlogAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

Balance Sheets Overview

Current Ratio
2425.85%
Quick Ratio
2425.85%
Cash Ratio
2386.05%
Debt to Asset Ratio
4.37%
Unit: Thousand (K) dollars
Assets Breakdown
    • Cash and cash equivalents
    • Accounts receivable
    • Restricted cash
    • Other noncurrent assets
Liabilities Breakdown
    • Additional paid-in capital
    • Accumulated deficit
    • Accounts payable
    • Others
Balance Sheets
2026-06-30
2025-09-30
2025-06-30
Cash and cash equivalents
125,172
5,227
5,417
Accounts receivable
500
-
-
Prepaid expenses and other current assets
1,588
1,601
1,030
Total current assets
127,260
6,828
6,447
Restricted cash
55
26
26
Property and equipment, net
-
0
1
Operating lease right-of-use asset
-
0
22
Other noncurrent assets
0
119
171
Total assets
127,315
6,973
6,667
Accounts payable
1,835
1,426
1,374
Accrued liabilities
3,136
1,220
2,066
Current portion of operating lease liability
-
0
24
Accrued compensation and benefits
275
621
192
Share liability
0
-
-
Insurance financing debt
0
211
314
Total current liabilities
5,246
3,478
3,970
Derivative liability
62
0
2
Other noncurrent liabilities
-
283
-
Contingent consideration obligation
259
-
75
Total liabilities
5,567
3,761
4,047
Series a convertible preferred stock, 0.01 par value, 7,000,000 shares authorized 200,000 issued and outstanding at june 30, 2026 and december 31, 2025
2
2
2
Common stock, 0.01 par value 450,000,000 and 300,000,000 shares authorized 173,595,201 and 159,444,017 shares issued and outstanding at june 30, 2026 and december 31, 2025, respectively
1,735
91
48
Additional paid-in capital
292,910
146,945
143,528
Accumulated deficit
-172,899
-143,826
-140,958
Total stockholders' equity
121,748
3,212
2,620
Total liabilities and stockholders' equity
127,315
6,973
6,667
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Cash and cashequivalents$125,172K (2210.73%↑ Y/Y)Prepaid expenses andother current assets$1,588K (54.17%↑ Y/Y)Accounts receivable$500K Total current assets$127,260K (1873.94%↑ Y/Y)Restricted cash$55K (111.54%↑ Y/Y)Total assets$127,315K (1809.63%↑ Y/Y)Total liabilities andstockholders' equity$127,315K (1809.63%↑ Y/Y)Total stockholders'equity$121,748K (4546.87%↑ Y/Y)Total liabilities$5,567K (37.56%↑ Y/Y)Accumulated deficit-$172,899K (-22.66%↓ Y/Y)Additional paid-in capital$292,910K (104.08%↑ Y/Y)Total currentliabilities$5,246K (32.14%↑ Y/Y)Contingent considerationobligation$259K (245.33%↑ Y/Y)Derivative liability$62K (3000.00%↑ Y/Y)Common stock, 0.01 parvalue 450,000,000 and...$1,735K (3514.58%↑ Y/Y)Series a convertiblepreferred stock, 0.01 par...$2K (0.00%↑ Y/Y)Accrued liabilities$3,136K (51.79%↑ Y/Y)Accounts payable$1,835K (33.55%↑ Y/Y)Accrued compensationand benefits$275K (43.23%↑ Y/Y)

PALISADE BIO, INC. (PALI)

PALISADE BIO, INC. (PALI)